Materna Medical Completes First Close of Series B2 Financing Round

Written By Milli Marketing

Materna Medical is disrupting a $6 billion worth market in the most common pelvic conditions women face.

Milli Marketing
Previous

Materna Medical Launches Groundbreaking Virtual Clinical Trial Evaluating Treatment of Vaginismus Symptoms Using the Milli™ Vaginal Dilator
Next

The Power Curve with Holly Scott, Guest: Tracy MacNeal